A new dosage strength of transdermal testosterone [`Androderm'; Paladin Labs] has been approved in Canada

Source: Inpharma, Volume 1, Number 1344, 2002 , pp. 22-22(1)

Publisher: Adis International

Keywords: Andropause, treatment; Development-status; Paladin-Labs; Product-approvals; Testosterone, therapeutic use; Transdermal

Language: English

Document Type: Short communication

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers